Table 2-3.
Selected Secondary Metrics for Monitoring CVD, NHANES 2009 to 2010
| In the Presence of CVD
|
In the Absence of CVD
|
|||
|---|---|---|---|---|
| No.* | % (SE)† | No.* | % (SE)† | |
| Total | 16 209 474 | 7.2 (0.4) | 199 590 596 | 92.8 (0.4) |
| CHD | 6 916 012 | 3.2 (0.3) | ||
| Stroke | 5 717 759 | 2.7 (0.2) | ||
| CHF | 4 320 227 | 2.0 (0.3) | ||
| Acute MI | 6 929 905 | 3.2 (0.3) | ||
| Health behaviors | ||||
| Smoking | ||||
| Current smoker or smokers who quit <12 mo ago | 3 127 273 | 37.2 (4.9) | 40 760 066 | 20.1 (0.9) |
| PA | ||||
| PA: intermediate or poor‡ | 11 813 011 | 74.1 (5.1) | 115 561 988 | 58.4 (1.5) |
| PA: none | 10 598 908 | 64.5 (5.5) | 93 459 556 | 47.3 (1.2) |
| Diet, No. of metrics | ||||
| Total diet score 0–3 of 5 | 12 665 860 | 100.0 (0.00) | 161 370 154 | 99.7 (0.11) |
| Total diet score 0–1 of 5 | 9 540 532 | 70.1 (4.69) | 127 156 293 | 78.8 (1.42) |
| Overweight/obesity | ||||
| Overweight or obese (BMI ≥25.0 kg/m2) | 12 621 701 | 69.4 (4.1) | 134 879 713 | 68.1 (1.3) |
| Obese (BMI ≥30.0 kg/m2) | 7 763 611 | 49.0 (5.2) | 68 655 702 | 34.7 (1.0) |
| Health factors | ||||
| Hypertension | ||||
| Prevalence of BP ≥140/90 mm Hg or taking medications | 10 591 170 | 51.0 (5.0) | 53 523 895 | 28.5 (0.9) |
| Awareness among those with hypertension | 10 071 343 | 98.6 (0.3) | 42 436 782 | 70.6 (3.2) |
| Treatment those with hypertension | 9 819 244 | 97.4 (0.4) | 39 194 948 | 61.4 (2.9) |
| BP control to <140/<90 mm Hg among treated | 6 886 176 | 64.2 (9.5) | 27 323 649 | 72.4 (2.4) |
| BP control to <140/<90 mm Hg among hypertensive | 6 886 176 | 62.3 (9.4) | 27 323 649 | 43.3 (2.8) |
| Hypercholesterolemia | ||||
| Prevalence of total cholesterol ≥240 mg/dL or taking medications | 8 201 829 | 37.1 (4.2) | 48 701 198 | 25.7 (0.7) |
| Awareness among those with hypercholesterolemia | 7 742 127 | 84.6 (8.0) | 35 174 931 | 59.9 (2.6) |
| Treatment among those with hypercholesterolemia | 7 219 078 | 79.3 (8.5) | 25 405 334 | 38.7 (2.4) |
| Cholesterol control to <200 mg/dL among treated | 6 659 732 | 95.0 (1.4) | 22 804 724 | 90.4 (1.2) |
| Cholesterol control to <200 mg/dL among hypercholesterolemia | 6 659 732 | 75.0 (8.9) | 22 804 724 | 34.7 (2.4) |
| Diabetes mellitus | ||||
| Prevalence of fasting glucose ≥125 mg/dL or taking medications | 4 769 759 | 15.2 (2.2) | 21 078 443 | 10.3 (1.1) |
| Awareness among diabetics | 4 006 153 | 90.4 (2.3) | 14 242 760 | 64.3 (4.6) |
| Treatment among diabetics | 3 935 446 | 87.1 (3.2) | 13 391 291 | 58.4 (5.3) |
| Blood glucose control among treated | 1 527 151 | 32.6 (9.9) | 5 878 676 | 45.0 (8.0) |
| Blood glucose control among diabetics | 1 527 151 | 27.2 (8.7) | 5 878 676 | 25.5 (5.9) |
BMI indicates body mass index; BP, blood pressure; CHD, coronary heart disease; CHF, congestive heart failure; CVD, cardiovascular disease; MI, myocardial infarction; NHANES, National Health and Nutrition Examination Survey; PA, physical activity; and SE, standard error.
*
Weighted sample size.
†
Standardized to the age distribution of the 2000 US Standard population.
‡
Moderate <150 min/wk AND Vigorous <75 min/wk AND Combined <150 min/wk.